Search Results for "Benzodiazepine Multiple Sclerosis"

20:40 EST 6th March 2015 | BioPortfolio

Matching Channels

ATX-MS-1467 for patients with multiple sclerosis (MS)

ATX-MS-1467 is a novel treatment that was developed with the aim of working with the immune system to treat the underlying cause of disease rather than just treating the symptoms or suppressing the ...

Systemic Sclerosis

Diffuse mesangial sclerosis

Amyotrophic lateral sclerosis ALS

B lymphocyte stimulator BlyS

Treatment of inflammatory and autoimmune diseases such as systemic lupus erythematosus (SLE), rheumatoid arthritis and multiple sclerosis.

Matching News

Multiple sclerosis drug candidate shows new promise

Positive new data have been released on a drug candidate, RPC1063, for relapsing multiple sclerosis. According to the results from a six-month Phase 2 study of 258 multiple sclerosis patients, the dru...

[Comment] The systematic search for risk factors in multiple sclerosis

Substantial advances in multiple sclerosis research have occurred in recent years, from the advent of oral therapies for relapsing-remitting multiple sclerosis1 to the discovery of previously unknown ...

Two Ways Yoga Can Help Benefit Multiple Sclerosis

March has been proclaimed Multiple Sclerosis Awareness Month, spotlighting MS awareness, support and resources. Multiple sclerosis (MS) is a chronic disease of the nervous system that affects differen...

Multiple sclerosis: First evidence of a rogue protein

A rogue protein has been identified in multiple sclerosis, which attacks the body's central nervous system. Reporting for the first time, researchers believe this finding could pave the way for better...

Multiple Sclerosis Partnering 2009-2014

Recently added to the BioPortfolio report store, Multiple Sclerosis Partnering 2009-2014 is a new report from Current Partnering published on 2014-10-31. This 150+-page report is available from $995....

New research finds the first evidence of a rogue protein in multiple sclerosis

In a new study published today in the journal Frontiers in Neurology, a team of researchers led by the University of Surrey, have identified a rogue protein in multiple sclerosis, which attacks the bo...

Cells from placentas safe for patients with multiple sclerosis

(The Mount Sinai Hospital / Mount Sinai School of Medicine) Patients with multiple sclerosis were able to safely tolerate treatment with cells cultured from human placental tissue, according to a stud...

MS drug candidate shows new promise

Positive new data have been released on a drug candidate, RPC1063, for relapsing multiple sclerosis. According to the results from a six-month Phase 2 study of 258 multiple sclerosis patients, the dru...

Matching PubMed Articles

The influence of patient demographics, disease characteristics and treatment on brain volume loss in Trial Assessing Injectable Interferon vs FTY720 Oral in Relapsing-Remitting Multiple Sclerosis (TRANSFORMS), a phase 3 study of fingolimod in multiple sclerosis.

Patients with multiple sclerosis (MS) lose brain volume (BV) faster than healthy individuals.

Immunopathology of multiple sclerosis.

Multiple sclerosis is an inflammatory demyelinating disease affecting the central nervous system and considered one of the leading causes of disability in young adults. The precise cause of multiple s...

Characterizing cognitive function during relapse in multiple sclerosis.

To characterize neuropsychological (NP) test performance during multiple sclerosis (MS) relapse and recovery.

School performance as a marker of cognitive decline prior to diagnosis of multiple sclerosis.

For many years, cognitive impairment has been established as a well-known symptom of multiple sclerosis. Moreover, we know that it was present even at the beginning of the disease.

Interferon beta treatment of multiple sclerosis increases serum interleukin-7.

Interleukin-7 (IL-7) is a non-redundant cytokine for T-cell development and survival. The IL-7 signaling pathway has been genetically and functionally associated with several autoimmune diseases inclu...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement